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PBMCs were gated by FSC vs. SSC characteristics. T cells were selected based on the expression of CD3 and the absence of CD56. CD4 + CD8 -CD45RO + memory T cells were gated into CCR4 + CCR6 + CXCR3 -TH17 cells, as described in literature. 1 (B) Graphs displaying proportions within PBMCs (upper row), within CD4 + T cells (middle row), and total cell numbers (lower row) of CD4 + T cell subsets derived from alemtuzumab treated RRMS patients (n=12) at baseline (filled triangles) and 6-month follow-up (open triangles). P-values were calculated by paired student τ-test or Wilcoxon matched-pairs signed rank test, respectively, *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.
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